Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)

Bibliographic Details
Main Authors:	R. Karnik, A. Trailokya, P. Kamlesh, Q. Mukaddam, M. Naik
Format:	Article
Language:	English
Published:	Elsevier 2014-11-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483214005264

id	doaj-2a1572cb6a3c4517b3fa0dec57ec69f4
record_format	Article
spelling	doaj-2a1572cb6a3c4517b3fa0dec57ec69f42020-11-24T20:43:29ZengElsevierIndian Heart Journal0019-48322014-11-0166S2S8710.1016/j.ihj.2014.10.241Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)R. KarnikA. TrailokyaP. KamleshQ. MukaddamM. Naikhttp://www.sciencedirect.com/science/article/pii/S0019483214005264
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	R. Karnik A. Trailokya P. Kamlesh Q. Mukaddam M. Naik
spellingShingle	R. Karnik A. Trailokya P. Kamlesh Q. Mukaddam M. Naik Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study) Indian Heart Journal
author_facet	R. Karnik A. Trailokya P. Kamlesh Q. Mukaddam M. Naik
author_sort	R. Karnik
title	Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)
title_short	Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)
title_full	Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)
title_fullStr	Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)
title_full_unstemmed	Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)
title_sort	evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (earth study)
publisher	Elsevier
series	Indian Heart Journal
issn	0019-4832
publishDate	2014-11-01
url	http://www.sciencedirect.com/science/article/pii/S0019483214005264
work_keys_str_mv	AT rkarnik evaluationandassessmentofrosuvastatin40mgtreatmentinhighriskdyslipidemicpatientsearthstudy AT atrailokya evaluationandassessmentofrosuvastatin40mgtreatmentinhighriskdyslipidemicpatientsearthstudy AT pkamlesh evaluationandassessmentofrosuvastatin40mgtreatmentinhighriskdyslipidemicpatientsearthstudy AT qmukaddam evaluationandassessmentofrosuvastatin40mgtreatmentinhighriskdyslipidemicpatientsearthstudy AT mnaik evaluationandassessmentofrosuvastatin40mgtreatmentinhighriskdyslipidemicpatientsearthstudy
_version_	1716819750577766400

Evaluation and assessment of rosuvastatin 40 mg treatment in high risk dyslipidemic patients (EARTH Study)

Similar Items